At Squip, we strive to introduce high quality products that will help for a better and healthier world. Under the direction of our medical staff, our products are carefully researched for their effectiveness and efficiency before they are released into the market. The labeling and presentation of our products are in compliance with all regulations. Our products are selected for their ability to make a substantial difference in people's lives and for their contribution to good health. Squip began its operations in 2002. Its 7,000 square foot manufacturing/distribution center and corporate office are located in Central New Jersey. President and CEO is Hans Kahlau.
In 2004, ENTpro and Squip formed a joint venture for the global market. Squip’s products are successfully sold in 27 different countries world-wide – including: the United States, Canada, Venezuela, Costa Rica, Barbados, Germany, Poland, Spain, Sweden, Norway, Denmark, England, Japan, Korea, Holland, Belgium, Luxemburg, Portugal, South Korea, Greece, Thailand, El Salvador and Mexico.